Ask Questions, Get Industry Insights … Instantly

Save time and get answers to complex questions with AI chat

Recent Questions

Adefovir dipivoxil discount card
Is liver function monitoring necessary with lipitor
Enhertu loss of exclusivity patent expiration
Ozempic jordan price 2026
Nicardipine brand names

Relugolix patent?

See the DrugPatentWatch profile for Relugolix

Relugolix (an oral GnRH antagonist for advanced prostate cancer) – the patent landscape in a nutshell

| Patent | Filing / Publication | Key Claims | Status (as of July 2026) | Notes |
|--------|----------------------|------------|--------------------------|-------|
| WO 2015/090586